Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Abbou

Showing results (221-230 of 244) with videos related to

Pageof 25
Sort By:
The Journal of Pathology|October 1, 2008
Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progressionS Azoulay, S Terry, M Chimingqi, et al.
Cancer Research|December 18, 2003
FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladderAshraf A Bakkar, Herve Wallerand, François Radvanyi, et al.
Cancer|October 7, 2005
Proposal for revision of the TNM classification system for renal cell carcinomaVincenzo Ficarra, François Guillè, Luigi Schips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Gefitinib inhibits the growth and invasion of urothelial carcinoma cell lines in which Akt and MAPK activation is dependent on constitutive epidermal growth factor receptor activationGaëlle Nicolle, Ahmad Daher, Pascale Maillé, et al.
Oncogene|October 20, 2010
Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor developmentG Sugano, I Bernard-Pierrot, M Laé, et al.
Surgical Endoscopy|April 27, 2004
Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic SurgeryD Korolija, S Sauerland, S Wood-Dauphinée, et al.
The American Journal of Pathology|June 8, 2001
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumorsC Billerey, D Chopin, M H Aubriot-Lorton, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 22, 2007
[Comparison of open and laparoscopic partial nephrectomy: a French multicentre experience]Maxime Crepel, Jean-Christophe Bernhard, Laurent Bellec, et al.
The Journal of Urology|May 6, 2004
Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experienceJean-Jacques Patard, Oleg Shvarts, John S Lam, et al.
European Urology|January 24, 2007
Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indicationJean-Jacques Patard, Allan J Pantuck, Maxime Crepel, et al.
Pageof 25

Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
The Journal of Pathology|October 1, 2008
Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progressionS Azoulay, S Terry, M Chimingqi, et al.
Cancer Research|December 18, 2003
FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladderAshraf A Bakkar, Herve Wallerand, François Radvanyi, et al.
Cancer|October 7, 2005
Proposal for revision of the TNM classification system for renal cell carcinomaVincenzo Ficarra, François Guillè, Luigi Schips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Gefitinib inhibits the growth and invasion of urothelial carcinoma cell lines in which Akt and MAPK activation is dependent on constitutive epidermal growth factor receptor activationGaëlle Nicolle, Ahmad Daher, Pascale Maillé, et al.
Oncogene|October 20, 2010
Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor developmentG Sugano, I Bernard-Pierrot, M Laé, et al.
Surgical Endoscopy|April 27, 2004
Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic SurgeryD Korolija, S Sauerland, S Wood-Dauphinée, et al.
The American Journal of Pathology|June 8, 2001
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumorsC Billerey, D Chopin, M H Aubriot-Lorton, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 22, 2007
[Comparison of open and laparoscopic partial nephrectomy: a French multicentre experience]Maxime Crepel, Jean-Christophe Bernhard, Laurent Bellec, et al.
The Journal of Urology|May 6, 2004
Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experienceJean-Jacques Patard, Oleg Shvarts, John S Lam, et al.
European Urology|January 24, 2007
Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indicationJean-Jacques Patard, Allan J Pantuck, Maxime Crepel, et al.
Pageof 25